P. J. Lachmann

10.2k citations

201 papers · 8.0k indexed · 1 hit paper · h-index 50

Impact in

Immunology top 0.2%
- Complement system in diseases
- T-cell and B-cell Immunology
Hematology top 0.5%
- Blood groups and transfusion

Papers in

Immunology 121
- Complement system in diseases 75
- Immunodeficiency and Autoimmune Disorders 17
- Immune Cell Function and Interaction 14
Hematology 58
- Blood groups and transfusion 41

Co-authors: R. A. Harrison R. A. Thompson Herman Waldmann Mark Walport Pamela Ewan Alun Davies G Hale D K Peters
Journals: Clinical & Experimental Immunology (21 papers)The Journal of Immunology (11 papers)Scandinavian Journal of Immunology (7 papers)Biochemical Journal (6 papers)The Lancet (6 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

P. J. Lachmann

197 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. 1989 · 547 citations

Peers

Countries citing papers authored by P. J. Lachmann

Since Specialization

Citations

This map shows the geographic impact of P. J. Lachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. J. Lachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. J. Lachmann more than expected).

Fields of papers citing papers by P. J. Lachmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. J. Lachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. J. Lachmann. The network helps show where P. J. Lachmann may publish in the future.

Co-authors

The 25 scholars most cited alongside P. J. Lachmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. J. Lachmann Line = papers co-authored together P. J. Lachmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preparing serum for functional complement assays Journal of Immunological Methods ·P. J. Lachmann	2009	61
2	Inhibition of antimicrobial peptides by group A streptococci: SIC and DRS Biochemical Society Transactions ·David J. Seilly, Barbara A. Fernie-King, P. J. Lachmann	2006	11
3	Determination of CD59 protein in normal human serum by enzyme immunoassay, using octyl-glucoside detergent to release glycosyl-phosphatidylinositol-CD59 from lipid complex Immunology Letters ·Ana Paula Garcia Landi, A B Wilson, Alun Davies, P. J. Lachmann, Virgínia Paes Leme Ferriani, David J. Seilly, Ana Isabel de Assis-Pandochi	2003	13
4	Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. Journal of Clinical Investigation ·Mark Wing, T. Moreau, Judith Greenwood, Richard Smith, G Hale, John D. Isaacs, Herman Waldmann, P. J. Lachmann, Alastair Compston	1996	185
5	Bee venom immunotherapy induces a shift in cytokine responses from a TH‐2 to a TH‐1 dominant pattern: comparison of rush and conventional immunotherapy Clinical & Experimental Allergy ·Sheena McHugh, John Deighton, A. G. STEWART, P. J. Lachmann, Pamela Ewan	1995	147
6	Complement-mediated adipocyte lysis by nephritic factor sera. The Journal of Experimental Medicine ·Peter W. Mathieson, Reinhard Würzner, D B Oliveria, P. J. Lachmann, D K Peters	1993	77
7	Xivth international complement workshop cambridge england uk september 15 20 1991 P. J. Lachmann, R A Harrison, M. J. Hobart, Reinhard Wuerzner	1991	1
8	The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens Journal of General Virology ·David A. Davis, B. Chaudhri, D. M. Stephens, C A Carne, Chrissie Willers, P. J. Lachmann	1990	26
9	Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis. The Journal of Experimental Medicine ·Seppo Meri, B. Paul Morgan, Mark Wing, Jennifer R. Jones, Alun Davies, Eckhard R. Podack, P. J. Lachmann	1990	49
10	2nd European Meeting on Complement in Human Disease Konrad Kölblea, G Lefranch, John O. Rasmussen, Robert B. Sim, Peter Späth, S.-E Svehagc, V Wahne, D Frangia, M Cicardia, M Cugnoa, Giuliana Bisiani, E Hackb, J Nuijensb, A Agostinia, Mark C. Poznansky, P. J. Lachmann, M Clear Di ', I. Fabrizi, C HACK, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1988	2
11	Cytolysis by Cloned Helper T Cells: Induction by Specific Antigen or by Anti‐CD3 Hybrid Antibodies Scandinavian Journal of Immunology ·Annapurna Vyakarnam, A. L. STRANGEWAYS, R. E. Glover, P. J. Lachmann	1988	1
12	The Capacity of Lymphoblastoid Cells to Activate the Alternative Complement Pathway Is Correlated with their Transformation by Epstein-Barr Virus The Journal of Immunology ·I. McConnell, P. J. Lachmann, Thomas F. Lint, George Klein	1978	1
13	The Physiological Breakdown of C3b The Journal of Immunology ·Ruth Harrison, P. J. Lachmann	1978	7
14	C6–C7: A Further “Complement Supergene” The Journal of Immunology ·P. J. Lachmann, M. J. Hobart	1978	8
15	ABSENCE OF VARIATION IN HUMAN C5 International Journal of Immunogenetics ·M. Amália Vaz‐Guedes, M. J. Hobart, P. J. Lachmann	1978	3
16	Deficiency of factor B of the complement system in sickle cell anaemia. BMJ ·Wendell A. Wilson, Graham R.V. Hughes, P. J. Lachmann	1976	47
17	The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·P. J. Lachmann, Lise Halbwachs	1975	121
18	REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLS The Journal of Experimental Medicine ·R. A. Thompson, P. J. Lachmann	1970	152
19	REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLS The Journal of Experimental Medicine ·P. J. Lachmann, R. A. Thompson	1970	211
20	IMMUNOLOGICAL REACTIONS AT THE CELL SURFACE British Medical Bulletin ·R.R.A. Coombs, P. J. Lachmann	1968	8

About P. J. Lachmann

P. J. Lachmann is a scholar working on Immunology, Hematology, Genetics, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 201 papers that have together received 8.0k indexed citations. Recurring topics across this work include Complement system in diseases (75 papers), Monoclonal and Polyclonal Antibodies Research (43 papers), Blood groups and transfusion (41 papers), Erythrocyte Function and Pathophysiology (25 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers), Glycosylation and Glycoproteins Research (19 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Immune Cell Function and Interaction (14 papers). The work is most often cited by research in Immunology (4.6k citations), Hematology (1.9k citations), Nephrology (676 citations), Genetics (1.0k citations) and Immunology and Allergy (485 citations). P. J. Lachmann has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include R. A. Harrison, R. A. Thompson, Herman Waldmann, Mark Walport, Pamela Ewan, Alun Davies, G Hale, D K Peters, John Deighton and Yara Maria Lucisano-Valim. Their work appears in journals such as Clinical & Experimental Immunology, The Journal of Immunology, Scandinavian Journal of Immunology, Biochemical Journal and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact